Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil vs Remifentanil in TIVA for Sinus Surgery
NCT05344911Phase 4Completed
- Sponsor
- Xijing Hospital
- Start
- Apr 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alfentanil in postoperative pain, sponsored by Xijing Hospital. Started Apr 2022; status: completed.
02
Drugs
alfentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05344911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05344911.